Two cases of malignant form of mucormycosis are presented. In spite of extensive treatment with surgery and antifungal drugs, both cases were fatal. Diminished cellular immunity was demonstrated and considered an important factor in the poor outcome.
Introduction
Malignant rhinocerebral mucormycoses (RCM) are not uncommon in patients with compromised host defences (Eisenberg, Wood and Boles, 1977; . Underlying conditions include leukaemia, lymphoma (Meyer, Rosen and Armstrong, 1972) , uncontrolled diabetes mellitus (Abramson, Wilson and Arky, 1967) , carcinomatosis, renal failure and effects of immunosuppressive therapy.
The progressive nature of the infection in these patients is thought to result from impaired cellular immunity (Tanphaichitra, Limsuwan and Panupornprapongs, 1978) . Two patients with RCM are described in whom the outcome was fatal in spite of intensive therapy. E rosette formation and 2,4-dinitrochlorobenzene sensitivity testing indicated impaired cellular immunity.
Case reports Case I
A 30-year-old Thai female with diabetic retinopathy and nephropathy was admitted to hospital with a history of facial pain for 5 days and periorbital swelling for 2 days. The diabetes was controlled with isophane insulin 10-15 u./day which she had been receiving for 2 years, but had stopped during the month before admission.
She was confused, had a mild pyrexia (380C) and her face was swollen, warm and tender particularly Amphotericin B was commenced but the infection progressed into the right orbital tissues. The patient died 27 days after admission.
Evaluation of cellular immunity
The cellular immune status of both patients was assessed by E rosette formation and 2,4-dinitrochlorobenzene sensitivity.
In vitro E rosette formation: the ability of the T cells to form rosette spontaneously by binding sheep erythrocytes to their surface was used as a marker for T cells. A leucocyte suspension 0.2 ml containing 106 cells was mixed with 0.2 ml of a 0.5%/ suspension of the sheep erythrocytes. The mixture was incubated in a water bath at 37°C for 5 min. The pellet was then gently resuspended and rosette-forming cells were counted in a cover slip preparation. One hundred lymphocytes were counted and all cells binding 2 or more sheep erythrocytes were considered to be T lymphocytes.
In vivo 2,4-Dinitrochlorobenzene (DNCB) reaction: the DNCB sensitization procedure consisted on the application of 2000 ,.g of DNCB in 0-1 ml of acetone to an area of skin 2 cm in diameter on the upper inner portion of the arm. Fourteen days later 100 jg Occasionally as in the first case there is a cutaneous involvement .
The condition usually has a rapid progress and frequently extends into the cranial cavity with fatal results. Therapy involves management of underlying conditions, surgical excision and the use of specific antifungal agents especially amphotericin B.
The rapidity of progress and the relative ineffectiveness of therapy may be due to impaired cellular immunity found in most patients with RCM. 
